[Convulsions after a test dose of ropivacaine and negative aspiration test for combined spinal-epidural analgesia for cesarean section].
Guasch
E
E
Almogueraa
J
J
Gilsanz
F
F
D000328:Adult; D000577:Amides / Q000008:administration & dosage / Q000009:adverse effects*; D000767:Anesthesia, Epidural; D000773:Anesthesia, Obstetrical; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects*; D002045:Bupivacaine / Q000008:administration & dosage; D002585:Cesarean Section; D004630:Emergencies; D004830:Epilepsy, Tonic-Clonic / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D005316:Fetal Distress; D006801:Humans; D007431:Intraoperative Complications / Q000139:chemically induced* / Q000188:drug therapy; D008738:Methyl Ethers; D011247:Pregnancy; D015742:Propofol / Q000627:therapeutic use; D011677:Punctures / Q000009:adverse effects*; D000077212:Ropivacaine; D000077149:Sevoflurane; D013390:Succinylcholine / Q000627:therapeutic use; D013610:Tachycardia / Q000139:chemically induced; D014680:Veins / Q000293:injuries*
D000577:Amides; D000779:Anesthetics, Local; D008738:Methyl Ethers; D000077149:Sevoflurane; D000077212:Ropivacaine; D013390:Succinylcholine; D005283:Fentanyl; D002045:Bupivacaine; D015742:Propofol